CoChat

Different hypertension thresholds and cognitive decline: a pooled analysis of three ageing cohorts

Open access
Ma, Yanjun, Hua, Rong, Yang, Zhenchun, Zhong, Baoliang, Yan, Li, Xie, Wuxiang · 2021 · BMC Medicine

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

Background: The 2017 American College of Cardiology (ACC)/American Heart Association (AHA) guidelines for high blood pressure (BP) in adults came up with a new definition of hypertension with a threshold BP level of 130/80 mmHg. But the 2018 European Society of Cardiology (ESC)/European Society of Hypertension (ESH) guidelines adhered to a conventional hypertension definition as BP ≥ 140/90 mmHg. We aimed to compare the trajectories of cognitive decline between participants with BP < 130/80 mmHg in all BP measurement waves and others with all BP < 140/90 mmHg. Methods: This pooled analysis involved middle-aged and older participants from three nationally representative ageing cohorts, including the Health and Retirement Study (HRS), the English Longitudinal Study of Ageing (ELSA), and the China Health Retirement Longitudinal Study (CHARLS). Participants were divided into the Normal (BP < 130/80 mmHg on all occasions throughout the study), the Borderline (BP < 140/90 mmHg on all occasions throughout the study but not in the Normal group), and the High (the rest of participants) BP groups. Global cognitive Z score was calculated from tests on memory, executive function, and orientation. Results: A total of 17,590 participants (HRS 6964, median follow-ups 12 years; ELSA 5334, median follow-ups 16 years; CHARLS 5292, median follow-ups 7 years) were included. No significant difference in global cognitive decline rate was detected between the Normal and the borderline groups (men, pooled β = − 0.006 standard deviation [SD]/year; 95% confidence interval [CI], − 0.020 to 0.008; P = 0.377; women, pooled β = 0.006 SD/year; 95% CI − 0.005 to 0.018; P = 0.269). Participants in the High group had a significantly faster cognitive decline (men, pooled β = − 0.011 SD/year; 95% CI − 0.020 to − 0.002; P = 0.013; women, pooled β = − 0.017 SD/year; 95% CI − 0.026 to − 0.008; P < 0.001) than that in the Borderline group. Conclusions: Individuals in the Borderline group did not experience significantly faster cognitive decline compared with those in the Normal group. It might not be necessary for individuals with borderline BP (between 130/80 and 140/90 mmHg) to initiate antihypertension therapy in consideration of cognitive decline.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12916-021-02165-4

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Flow chart of participant selection for this study
Fig. 1 Flow chart of participant selection for this studyCC BY · PubMed Central
Fig. 2 Mean differences in rate of cognitive change by sex. Solid lines represent adjusted mean differences in cognitive change of global cognition (a), memory (b), executive function (c), and orientation (d) after adjusting for age, race (except for the CHARLS), BMI, education, cohabitation status, current smoking, alcohol consumption, exercise, depressive symptoms, antihypertension medication, diabetes, hypercholesterolemia, coronary heart disease, stroke, cancer, and chronic lung disease. The shadows represent the 95% CIs. The detailed results are presented in Tables 2 and 3
Fig. 2 Mean differences in rate of cognitive change by sex. Solid lines represent adjusted mean differences in cognitive change of global cognition (a), memory (b), executive function (c), and orientation (d) after adjusting for age, race (except for the CHARLS), BMI, education, cohabitation status, current smoking, alcohol consumption, exercise, depressive symptoms, antihypertension medication, diabetes, hypercholesterolemia, coronary heart disease, stroke, cancer, and chronic lung disease. The shadows represent the 95% CIs. The detailed results are presented in Tables 2 and 3CC BY · PubMed Central
Fig. 3 Mean differences in rate of global cognitive change in sensitivity analyses. Solid lines represent adjusted mean differences in global cognition among participants without antihypertension medication using (a), hypotension (b), coronary heart disease or stroke (c), or with ≥ 2 BP measurements (d) after adjusting for age, race (except for the CHARLS), BMI, education, cohabitation status, current smoking, alcohol consumption, exercise, depressive symptoms, antihypertension medication, diabetes, hypercholesterolemia, coronary heart disease, stroke, cancer, and chronic lung disease. The shadows represent the 95% CIs. The detailed results are presented in Additional file 1: Tables S4 and S5
Fig. 3 Mean differences in rate of global cognitive change in sensitivity analyses. Solid lines represent adjusted mean differences in global cognition among participants without antihypertension medication using (a), hypotension (b), coronary heart disease or stroke (c), or with ≥ 2 BP measurements (d) after adjusting for age, race (except for the CHARLS), BMI, education, cohabitation status, current smoking, alcohol consumption, exercise, depressive symptoms, antihypertension medication, diabetes, hypercholesterolemia, coronary heart disease, stroke, cancer, and chronic lung disease. The shadows represent the 95% CIs. The detailed results are presented in Additional file 1: Tables S4 and S5CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 43 references

Research works printed but not linked: 2

  1. Higgins J Thomas J Chandler J Cumpston M Li T Page M Cochrane Handbook for Systematic Reviews of Interventions (Version 6.2) 2021
  2. Holden G Statistical Power Analysis for the Behavioral-Sciences, 2nd Edition - Cohen J Soc Work Health Care 1993 18 2 131 132

Cited by

See all 72

Metadata

Authors
Ma, Y., Hua, R., Yang, Z., Zhong, B., Yan, L., & Xie, W.
Affiliations
  • Peking University (CN)
  • Imperial College London (GB)
Corresponding author
  • Yan, Li
  • Xie, Wuxiang
Venue
BMC Medicine
Published
2021-11-01
Volume
19
Issue
1
Pages
287-287
ISSN
1741-7015 (ISSN-L)
OpenAlex
W3209608509
Cited by
64
References
43
Citations by year
2026: 17 · 2025: 18 · 2024: 12 · 2023: 14 · 2022: 3
FWCI
5.20
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • national natural science foundation of china (81974490)
  • 2019 Irma and Paul Milstein Program for Senior Health Research Project Award
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Keywords
hypertension threshold, cognitive decline, borderline hypertension, older adults, middle-aged adults, global cognitive function, sex differences, aging cohort, Health and Retirement Study, English Longitudinal Study of Ageing, memory, executive function, orientation, blood pressure
MeSH terms
Adult, Aged, Aging, Blood Pressure, Blood Pressure Determination, Female, Humans, Hypertension, Longitudinal Studies, Male, Middle Aged, United States, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Different hypertension thresholds and cognitive decline: a pooled analysis of three ageing cohorts. https://app.cochat.ai/papers/10.1186/s12916-021-02165-4
The paper
Ma, Y., Hua, R., Yang, Z., Zhong, B., Yan, L., & Xie, W. (2021). Different hypertension thresholds and cognitive decline: a pooled analysis of three ageing cohorts. BMC Medicine. https://doi.org/10.1186/s12916-021-02165-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.